US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Affimed NV

0.9300

-0.0590-5.97%

Volume:25.09K

Turnover:23.63K

Market Cap:15.24M

PE:-0.18

High:1.01

Open:0.9600

Low:0.9109

Close:0.9890

Loading ...

Overview Company News Filings

Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting

Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting

Affimed Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Affimed NV expected to post a loss of 81 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

Calendar of U.S. Earnings Expected in the Week Ahead

Affimed NV expected to post a loss of 81 cents a share - Earnings Preview

Affimed (AFMD) Gets a Buy from Truist Financial

Affimed Nv : H.c. Wainwright Cuts Target Price to $7 From $10

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Ardent Health Partners, Inc. (ARDT)

Affimed Shares Fall 32% on Clinical Update

Affimed’s AFM24/atezolizumab combination shows positive results in NSCLC trial

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

Affimed Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study

MT Newswires Live

Affimed reports ‘promising’ Phase 1 efficacy, safety data for AFM28

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy

Affimed: Acimtamig, AlloNK combination granted RMAT designation by FDA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AFMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AFMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AFMD\",,,,,undefined,":{"symbol":"AFMD","market":"US","secType":"STK","nameCN":"Affimed NV","latestPrice":0.93,"timestamp":1746035007768,"preClose":0.989,"halted":0,"volume":25088,"delay":0,"floatShares":15477591,"shares":16392343,"eps":-5.065942,"marketStatus":"Trading","change":-0.059,"latestTime":"04-30 13:56:29 EDT","open":0.96,"high":1.0095,"low":0.9109,"amount":23631.353088,"amplitude":0.099697,"askPrice":0.9599,"askSize":601,"bidPrice":0.9273,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-5.065942,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1410494400000,"exchange":"NASDAQ","adjPreClose":0.989,"preHourTrading":{"tag":"盘前","latestPrice":0.921,"preClose":0.989,"latestTime":"08:09 EDT","volume":1,"amount":0.921,"timestamp":1746014959949},"postHourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.989,"latestTime":"17:34 EDT","volume":1892,"amount":1839.5078,"timestamp":1745962458053},"volumeRatio":0.325821,"impliedVol":3.2789,"impliedVolPercentile":0.964},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AFMD\",,,,,undefined,":{"symbol":"AFMD","floatShares":15477591,"roa":"-49.42%","roe":"-149.48%","lyrEps":-7.837887,"volumeRatio":0.325821,"shares":16392343,"dividePrice":0,"high":1.0095,"amplitude":0.099697,"preClose":0.989,"low":0.9109,"week52Low":0.52,"pbRate":"0.78","psRate":"2.38","week52High":8.95,"institutionHeld":0,"latestPrice":0.93,"committee":-0.091735,"eps":-5.065942,"divideRate":0,"volume":25088,"delay":0,"ttmEps":-5.065942,"open":0.96,"prevYearClose":1.19,"prevWeekClose":0.9347,"prevMonthClose":0.7232,"prevQuarterClose":0.7232,"fiveDayClose":0.7703,"twentyDayClose":0.7099,"sixtyDayClose":0.98},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AFMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531759499","title":"Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531759499","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531759499?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:00","pubTimestamp":1745935200,"startTime":"0","endTime":"0","summary":"An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer  who received AFM24 at 480 mg weekly demonstrates that higher drug exposure  leads to improved objective response rate  and longer progression free survival   without a negative impact on safety. These findings will be incorporated in future AFM24 trials to further improve efficacy outcomes of patients treated with AFM24. MANNHEIM, Germany, April 29, 2025  -- Affimed N.V. , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today presented findings on an exposure-outcome analysis of its innate cell engager  AFM24, in patients with advanced or metastatic non-small cell lung cancer  in a poster session at the 2025 Annual Meeting of the American Association for Cancer Research .The analysis is based on post-hoc exposure-response data from 72 NSCLC patients treated with 480 mg of AFM24 monotherapy or a combination of AFM24 with atezolizumab. F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/affimed-shows-higher-exposure-afm24-140000007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PFS","OS","BK4181","ORR","BK4211","BK4195","PK","BK4139","BK4097","AFMD","BK4218"],"gpt_icon":0},{"id":"2529863391","title":"Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529863391","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529863391?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:05","pubTimestamp":1745417100,"startTime":"0","endTime":"0","summary":"MANNHEIM, Germany, April 23, 2025  -- Affimed N.V.  , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on the phase 2 LuminICE-203 study of its innate cell engager  acimtamig in combination with AlloNK  has been accepted for an oral presentation at the Annual Meeting of the American Society for Clinical Oncology  taking place May 30 – June 3, 2025 in Chicago, Illinois. In addition, two abstracts on AFM24 in combination with atezolizumab in non-small cell lung cancer  have been accepted as poster presentations.Details of the acimtamig oral presentation and AFM24 poster presentations are as follows:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/affimed-announces-acceptance-three-abstracts-140500793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1201861249.SGD","LU0417517546.SGD","LU0390134368.USD","LU0130102774.USD","IE00BQXX3F31.USD","LU1974910355.USD","LU0130517989.USD","LU2106854487.HKD","LU2237957811.SGD","LU0661504455.SGD","LU0256863811.USD","LU0648001328.SGD","LU1153585028.USD","SG9999004303.SGD","LU0154236417.USD","IE00BQXX3C00.GBP","LU0154245756.USD","LU0256863902.USD","ICE","LU2023250843.SGD","BK4107","LU0154245673.USD","GB00BDT5M118.USD","LU0477156953.USD","LU1917777945.USD","AFMD","LU0124676726.USD","IE00BQXX3D17.EUR","LU0980610538.SGD","LU0011850046.USD","BK4588","LU0689626769.HKD","LU0949170772.SGD","LU0738911758.USD","SGXZ23171101.USD","LU2237957902.USD","BK4139","AFG","BK4585","BK4117","LU2023250504.SGD","BK4112"],"gpt_icon":0},{"id":"2529090808","title":"Affimed Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529090808","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529090808?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:06","pubTimestamp":1745237189,"startTime":"0","endTime":"0","summary":"April 21 (Reuters) - Affimed NV ::*AFFIMED ANNOUNCES RECEIPT OF NASDAQ DEFICIENCY NOTICE REGARDING MINIMUM BID PRICE REQUIREMENT  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 21-APR-202510:30:00.05 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nRSD5yL0Jf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AFMD"],"gpt_icon":0},{"id":"2528606924","title":"Affimed NV  expected to post a loss of 81 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2528606924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528606924?lang=en_us&edition=fundamental","pubTime":"2025-04-18 20:56","pubTimestamp":1744981000,"startTime":"0","endTime":"0","summary":"Affimed NV  expected to post a loss of81cents a share - Earnings Preview Affimed NV AFMD.OQ, AFMD.O is expected to show a rise in quarterly revenue when it reports  results on April 21 (estimated) for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nL8N3QW0IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFMD"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","FC","BLRX","RLMD","FEMY","LNZA","PRGS","GEVO","TSAT","KYTX","ATAI","NNOX","DARE","CRDL","BW","GOVX","PVLA","REKR","UNCY","WGO","WBA","SGML","BCAB","SLRN","SPWH","TLSI","CELC","FTCI","BRZE","NUTX","BHST","EDAP","CLSD","CALC","LULU","AFMD","NCNO","IKT","INMB","MDAI","PVH","SKYH","INR","ADCT","GWH","ANGO","PENG","SDST","FBIO","WKSP"],"gpt_icon":0},{"id":"2522835210","title":"Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522835210","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522835210?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:30","pubTimestamp":1742934600,"startTime":"0","endTime":"0","summary":"MANNHEIM, Germany, March 25, 2025  -- Affimed N.V. , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on AFM24 dose optimization using exposure response analysis has been accepted for presentation as a poster at the Annual Meeting of the American Association for Cancer Research  taking place April 25-30, 2025 in Chicago, Illinois.Details of the poster presentation are as follows:. Authors:Anthony El-Khoueiry, Omar Saavedra, Juanita Lopez, Hye Ryun Kim, Daniela Morales-Espinosa, Daniel Schütz, Andre Overesch, Andreas Harstrick, Kerstin Pietzko. Session Category and Title: Phase II Clinical Trials 1. Session Date and Time:Tuesday, April 29, 2025, 9:00 AM – 12:00 PM CDT. Mary Beth Sandin Vice President, Marketing and CommunicationsE-Mail: m.sandin@affimed.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/affimed-announces-acceptance-afm24-abstract-203000443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4117","BK4139","AFMD","BK4107"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCS","WOOF","GOVX","KBH","BCAB","CLSD","EDAP","ABL","XFOR","FBIO","CTAS","PAYS","KOD","WGO","WBA","RVPH","UNCY","GRDN","MLKN","SDST","SLRN","RLMD","DLTR","CHWY","ANTX","SKYX","SURG","NUTX","DERM","LPTX","PDSB","MREO","OBIO","AFMD","ACRV","BEEM","CDLR","IOBT","PAYX","THRD","CNXC","IVA","MDAI","CRMD","TEN","IKT","MKC","ALUR","ZURA","CALC"],"gpt_icon":0},{"id":"2521286736","title":"Affimed NV  expected to post a loss of 81 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521286736","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521286736?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:52","pubTimestamp":1742561529,"startTime":"0","endTime":"0","summary":"Affimed NV  expected to post a loss of81cents a share - Earnings Preview Affimed NV AFMD.OQ, AFMD.O is expected to show a rise in quarterly revenue when it reports  results on March 24 (estimated) for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q413S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFMD"],"gpt_icon":0},{"id":"2492006499","title":"Affimed (AFMD) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492006499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492006499?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:25","pubTimestamp":1734524741,"startTime":"0","endTime":"0","summary":"In a report released today, Srikripa Devarakonda from Truist Financial assigned a Buy rating to Affimed (AFMD – Research Report). The company’s sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/affimed-afmd-gets-a-buy-from-truist-financial-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/affimed-afmd-gets-a-buy-from-truist-financial-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AFMD","BK4139"],"gpt_icon":0},{"id":"2492490187","title":"Affimed Nv : H.c. Wainwright Cuts Target Price to $7 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2492490187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492490187?lang=en_us&edition=fundamental","pubTime":"2024-12-18 19:17","pubTimestamp":1734520646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ049:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AFMD","BK4139"],"gpt_icon":0},{"id":"2492944376","title":"Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Ardent Health Partners, Inc. (ARDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492944376","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492944376?lang=en_us&edition=fundamental","pubTime":"2024-12-18 09:50","pubTimestamp":1734486633,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Affimed (AFMD – Research Report) and Ardent Health Partners, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-affimed-afmd-and-ardent-health-partners-inc-ardt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-affimed-afmd-and-ardent-health-partners-inc-ardt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARDT","HCSG","BK4139","BK4137","AFMD","BK4185"],"gpt_icon":0},{"id":"2492996516","title":"Affimed Shares Fall 32% on Clinical Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996516","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492996516?lang=en_us&edition=fundamental","pubTime":"2024-12-18 02:04","pubTimestamp":1734458689,"startTime":"0","endTime":"0","summary":"After disclosing revised clinical results for its AFM24/atezolizumab combination treatment in non-small cell lung cancer, Affimed N.V.  shares dropped 32% to $1.44 on Tuesday. Although the outcomes revealed minimal clinical efficacy in highly pretreated individuals, investor response points to questions over the relevance of the findings or the economic possibilities of the treatment.GuruFocus has detected 8 Warning Signs with AFMD.With tumor reduction seen in 48% of the 33 patients studied, the combination treatment had an overall response rate of 21% in the EGFR wild-type group. Median progression-free survival was 5.6 months; the disease control rate was 76%.With an ORR of 24% and a DCR of 71% among 17 patients, the EGFR mutant group did somewhat better. Five patients were still on therapy for more than ten months, therefore median PFS also measured 5.6 months.Higher AFM24 exposure patients had better results, according to a post-hoc exposure-response study containing an ORR of 46% ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gl.H4nENbLXSRe03.Bos.g--~B/aD0zNjY7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/15af21c53224ce854302d72122cdb690","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gl.H4nENbLXSRe03.Bos.g--~B/aD0zNjY7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/15af21c53224ce854302d72122cdb690"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/affimed-shares-fall-32-clinical-180449678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Affimed Shares Fall 32% on Clinical Update","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AFMD"],"gpt_icon":0},{"id":"2492958530","title":"Affimed’s AFM24/atezolizumab combination shows positive results in NSCLC trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492958530","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492958530?lang=en_us&edition=fundamental","pubTime":"2024-12-17 19:35","pubTimestamp":1734435311,"startTime":"0","endTime":"0","summary":"Affimed (AFMD) announced updated clinical data from the ongoing AFM24-102 trial of AFM24/atezolizumab combination therapy in heavily pretreated NSC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/affimeds-afm24-atezolizumab-combination-shows-positive-results-in-nsclc-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/affimeds-afm24-atezolizumab-combination-shows-positive-results-in-nsclc-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AFMD"],"gpt_icon":0},{"id":"2491634772","title":"Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2491634772","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491634772?lang=en_us&edition=fundamental","pubTime":"2024-12-16 14:10","pubTimestamp":1734329448,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Affimed (AFMD – Research Report), Editas Medicine (EDIT – Researc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-affimed-afmd-editas-medicine-edit-and-trevi-therapeutics-trvi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-affimed-afmd-editas-medicine-edit-and-trevi-therapeutics-trvi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","TRVI","BK4137","BK4556","AFMD","EDIT","BK4007"],"gpt_icon":0},{"id":"2490092706","title":"Affimed Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490092706","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490092706?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:35","pubTimestamp":1733834100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AFMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2024 07:35 ET (12:35 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFMD"],"gpt_icon":0},{"id":"2490701191","title":"Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2490701191","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490701191?lang=en_us&edition=fundamental","pubTime":"2024-12-10 03:02","pubTimestamp":1733770962,"startTime":"0","endTime":"0","summary":"Affimed (AFMD) said Monday that AFM28 showed \"promising\" efficacy and safety results evaluating the drug candidate in patients with relapsed/refractory acute myeloid leukemia in an ongoing phase 1 stu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AFMD"],"gpt_icon":0},{"id":"2490570937","title":"Affimed reports ‘promising’ Phase 1 efficacy, safety data for AFM28","url":"https://stock-news.laohu8.com/highlight/detail?id=2490570937","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490570937?lang=en_us&edition=fundamental","pubTime":"2024-12-10 02:35","pubTimestamp":1733769317,"startTime":"0","endTime":"0","summary":"Affimed (AFMD) N.V. announced the oral presentation of data on AFM28 at the 66th ASH Annual Meeting and Exposition. The data, derived from the firs...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/affimed-reports-promising-phase-1-efficacy-safety-data-for-afm28?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/affimed-reports-promising-phase-1-efficacy-safety-data-for-afm28?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AFMD","BK4139"],"gpt_icon":0},{"id":"2490753325","title":"Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2490753325","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490753325?lang=en_us&edition=fundamental","pubTime":"2024-12-09 01:00","pubTimestamp":1733677200,"startTime":"0","endTime":"0","summary":"The combination of acimtamig with AlloNK demonstrated an overall response rate of 86% and complete response of 55% in 22 heavily pretreated patients with R/R cHL, who have exhausted all standard of care treatments. The combination showed a well-manageable safety profile with no unexpected safety signals. MANNHEIM, Germany, Dec. 08, 2024  -- Affimed N.V.  , a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the presentation of data in a poster session at the 66th ASH Annual Meeting and Exposition. The dataset includes 22 patients from the run-in phase of the LuminICE-203  phase 2 open-label, multicenter, multi-cohort study. The trial evaluates the safety and efficacy of the combination of acimtamig  with Artiva Biotherapeutics’ allogeneic NK cell AlloNK in patients with R/R cHL.Acimtamig  is a first-in-class ICE that uniquely activates the innate immune system to destroy CD30-positive hematologic tumors. Acimt","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z3uhFOknuNPk4kuWaxxLPw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/dbbba12c81b876466ec0f745c48ed883","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z3uhFOknuNPk4kuWaxxLPw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/dbbba12c81b876466ec0f745c48ed883"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/affimed-announces-positive-results-demonstrating-170000799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFMD"],"gpt_icon":0},{"id":"2489553412","title":"AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2489553412","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489553412?lang=en_us&edition=fundamental","pubTime":"2024-12-06 23:36","pubTimestamp":1733499360,"startTime":"0","endTime":"0","summary":"Affimed N.V. AFMD announced that the FDA has granted the Regenerative Medicine Advanced Therapy  designation to its pipeline candidate, acimtamig .The regulatory body granted the RMAT designation to acimtamig in combination with Artiva Biotherapeutic’s ARTV AlloNK  for the treatment of relapsed or refractory Hodgkin Lymphoma .Despite the FDA’s RMAT designation, shares of Affimed were down 6.5% on Dec. 5 following the announcement of the news. The stock, however, rebounded in after-hour trading and was up 5.6%.The RMAT designation provides the candidate with increased opportunities to meet FDA officials, as well as arrange early meetings to discuss potential surrogate or intermediate endpoints. It opens up early interactions between the FDA and sponsors to facilitate accelerated approval and potential priority review of a product’s biologics license application.Year to date, shares of Affimed have plunged 62.9% compared with the industry’s decline of 8%.In the past 60 days, estimates fo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/afmd-stock-down-despite-fdas-153600588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","SPRO","ARTV","BK4139","CSTL","AFMD"],"gpt_icon":0},{"id":"2489407432","title":"Affimed: Acimtamig, AlloNK combination granted RMAT designation by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2489407432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489407432?lang=en_us&edition=fundamental","pubTime":"2024-12-05 19:35","pubTimestamp":1733398534,"startTime":"0","endTime":"0","summary":"Affimed (AFMD) announced that the U.S. FDA has granted RMAT designation to the combination therapy of Affimed’s innate cell engager acimtamig and A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/affimed-acimtamig-allonk-combination-granted-rmat-designation-by-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/affimed-acimtamig-allonk-combination-granted-rmat-designation-by-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AFMD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AFMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-14","symbol":"AFMD","fiscalQuarterEnding":"2024/09","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2024-09-05","symbol":"AFMD","fiscalQuarterEnding":"2024/06","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725508800000,"reportTimeType":"pre","actualEps":-1.09},{"market":"US","date":"2024-06-12","symbol":"AFMD","fiscalQuarterEnding":"2024/03","expectedEps":-1.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1718164800000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2024-03-28","symbol":"AFMD","fiscalQuarterEnding":"2023/12","expectedEps":-1.59,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-2.2},{"market":"US","date":"2024-03-11","symbol":"AFMD","defaultRemindTime":1710163800000,"type":"split","dateTimestamp":1710129600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AFMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AFMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1712203200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AFMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AFMD","date":"2025-04-28","current":-0.19246,"percent":0.978084,"low":-27.097699,"twenty":-12.502564,"median":-4.11121,"eighty":-0.634381,"high":-0.120825,"avg":-6.363091,"sd":6.904302,"marketCap":15321923},"quantilePoints":[{"date":"2020-05-01","current":-4.34734,"twenty":-14.077879,"median":-4.903817,"eighty":-2.413795,"marketCap":154787299},{"date":"2020-05-08","current":-4.905386,"twenty":-14.070713,"median":-4.893264,"eighty":-2.421409,"marketCap":172324776},{"date":"2020-05-15","current":-5.13745,"twenty":-13.992737,"median":-4.822478,"eighty":-2.421409,"marketCap":179949766},{"date":"2020-05-22","current":-6.466623,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":227987203},{"date":"2020-05-29","current":-6.972054,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":250862174},{"date":"2020-06-05","current":-7.244337,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":265349655},{"date":"2020-06-12","current":-6.415438,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":233324697},{"date":"2020-06-19","current":-8.165687,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":295849615},{"date":"2020-06-26","current":-7.409409,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":353037041},{"date":"2020-07-02","current":-7.292077,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":348462047},{"date":"2020-07-10","current":-6.992473,"twenty":-13.903484,"median":-4.822478,"eighty":-2.421409,"marketCap":336262063},{"date":"2020-07-17","current":-6.929913,"twenty":-13.84548,"median":-4.822478,"eighty":-2.421409,"marketCap":336643312},{"date":"2020-07-24","current":-6.076909,"twenty":-13.81,"median":-4.822478,"eighty":-2.421409,"marketCap":300424609},{"date":"2020-07-31","current":-5.352721,"twenty":-13.81,"median":-4.822478,"eighty":-2.421409,"marketCap":269162150},{"date":"2020-08-07","current":-5.798487,"twenty":-13.714722,"median":-4.822478,"eighty":-2.421409,"marketCap":290512122},{"date":"2020-08-14","current":-5.516366,"twenty":-13.590183,"median":-4.822478,"eighty":-2.421409,"marketCap":289811521},{"date":"2020-08-21","current":-6.186639,"twenty":-13.55172,"median":-4.822478,"eighty":-2.421409,"marketCap":323608783},{"date":"2020-08-28","current":-5.51899,"twenty":-13.455508,"median":-4.822478,"eighty":-2.421409,"marketCap":291501384},{"date":"2020-09-04","current":-5.291352,"twenty":-13.405685,"median":-4.822478,"eighty":-2.421409,"marketCap":277137548},{"date":"2020-09-11","current":-5.513755,"twenty":-13.381116,"median":-4.822478,"eighty":-2.421409,"marketCap":289811521},{"date":"2020-09-18","current":-6.094795,"twenty":-13.375875,"median":-4.822478,"eighty":-2.421409,"marketCap":321073989},{"date":"2020-09-25","current":-5.453753,"twenty":-13.365986,"median":-4.822478,"eighty":-2.421409,"marketCap":281362206},{"date":"2020-10-02","current":-5.19822,"twenty":-13.365986,"median":-4.822478,"eighty":-2.421409,"marketCap":270378096},{"date":"2020-10-09","current":-5.958343,"twenty":-13.365986,"median":-4.822478,"eighty":-2.421409,"marketCap":312624673},{"date":"2020-10-16","current":-5.7661,"twenty":-13.359131,"median":-4.822478,"eighty":-2.421409,"marketCap":299950700},{"date":"2020-10-23","current":-5.304779,"twenty":-13.307253,"median":-4.822478,"eighty":-2.421409,"marketCap":278827411},{"date":"2020-10-30","current":-5.1597,"twenty":-13.307253,"median":-4.822478,"eighty":-2.421409,"marketCap":266998369},{"date":"2020-11-06","current":-5.474252,"twenty":-13.307253,"median":-4.822478,"eighty":-2.421409,"marketCap":288966590},{"date":"2020-11-13","current":-8.360511,"twenty":-13.307253,"median":-4.869903,"eighty":-2.481415,"marketCap":390401096},{"date":"2020-11-20","current":-9.317581,"twenty":-13.307253,"median":-4.915965,"eighty":-2.508488,"marketCap":436330637},{"date":"2020-11-27","current":-9.897268,"twenty":-13.307253,"median":-4.968794,"eighty":-2.528233,"marketCap":467244751},{"date":"2020-12-04","current":-10.358792,"twenty":-13.307253,"median":-5.064665,"eighty":-2.56109,"marketCap":496392344},{"date":"2020-12-11","current":-12.354962,"twenty":-13.307253,"median":-5.140131,"eighty":-2.576195,"marketCap":590901207},{"date":"2020-12-18","current":-11.633134,"twenty":-13.307253,"median":-5.16143,"eighty":-2.59678,"marketCap":561753614},{"date":"2020-12-24","current":-13.172766,"twenty":-13.307253,"median":-5.170824,"eighty":-2.612727,"marketCap":633853100},{"date":"2020-12-31","current":-11.822892,"twenty":-13.307253,"median":-5.204051,"eighty":-2.631766,"marketCap":571056508},{"date":"2021-01-08","current":-12.540383,"twenty":-13.307253,"median":-5.253997,"eighty":-2.649174,"marketCap":606379591},{"date":"2021-01-15","current":-16.902492,"twenty":-13.381116,"median":-5.291111,"eighty":-2.670663,"marketCap":806930032},{"date":"2021-01-22","current":-15.909608,"twenty":-13.421666,"median":-5.298716,"eighty":-2.686829,"marketCap":764706949},{"date":"2021-01-29","current":-14.021055,"twenty":-13.527721,"median":-5.321944,"eighty":-2.725956,"marketCap":672050739},{"date":"2021-02-05","current":-14.679591,"twenty":-13.559478,"median":-5.344297,"eighty":-2.762501,"marketCap":697267303},{"date":"2021-02-12","current":-14.925476,"twenty":-13.710735,"median":-5.372294,"eighty":-2.787311,"marketCap":714273822},{"date":"2021-02-19","current":-14.786788,"twenty":-13.84548,"median":-5.392213,"eighty":-2.80536,"marketCap":708409505},{"date":"2021-02-26","current":-13.919711,"twenty":-13.903484,"median":-5.428286,"eighty":-2.839246,"marketCap":665013559},{"date":"2021-03-05","current":-13.014988,"twenty":-13.924057,"median":-5.45128,"eighty":-2.873936,"marketCap":612234705},{"date":"2021-03-12","current":-18.230113,"twenty":-13.965587,"median":-5.456788,"eighty":-2.894567,"marketCap":859708886},{"date":"2021-03-19","current":-20.763966,"twenty":-14.056956,"median":-5.472038,"eighty":-2.909032,"marketCap":975822365},{"date":"2021-03-26","current":-19.56906,"twenty":-14.12343,"median":-5.484544,"eighty":-2.943729,"marketCap":911314877},{"date":"2021-04-01","current":-19.640463,"twenty":-14.225529,"median":-5.492481,"eighty":-2.965871,"marketCap":912487740},{"date":"2021-04-09","current":-24.345426,"twenty":-14.356773,"median":-5.511778,"eighty":-2.975426,"marketCap":1142368971},{"date":"2021-04-16","current":-22.829433,"twenty":-14.509978,"median":-5.520505,"eighty":-2.997469,"marketCap":1131243790},{"date":"2021-04-23","current":-26.32135,"twenty":-14.596075,"median":-5.579305,"eighty":-3.010695,"marketCap":1313242003},{"date":"2021-04-30","current":-25.554515,"twenty":-14.690402,"median":-5.616252,"eighty":-3.029848,"marketCap":1271608425},{"date":"2021-05-07","current":-23.211086,"twenty":-14.788977,"median":-5.66111,"eighty":-3.050322,"marketCap":1166929714},{"date":"2021-05-14","current":-20.849197,"twenty":-14.828882,"median":-5.687551,"eighty":-3.055969,"marketCap":1046787104},{"date":"2021-05-21","current":-21.706939,"twenty":-14.92571,"median":-5.724351,"eighty":-3.067264,"marketCap":1094368336},{"date":"2021-05-28","current":-20.92832,"twenty":-15.040221,"median":-5.75298,"eighty":-3.092641,"marketCap":1055113819},{"date":"2021-06-04","current":-19.144153,"twenty":-15.158244,"median":-5.768536,"eighty":-3.108417,"marketCap":963519948},{"date":"2021-06-11","current":-19.374821,"twenty":-15.25283,"median":-5.790108,"eighty":-3.126035,"marketCap":969467602},{"date":"2021-06-18","current":-19.501737,"twenty":-15.333766,"median":-5.814802,"eighty":-3.13059,"marketCap":956382763},{"date":"2021-06-25","current":-19.839945,"twenty":-15.507369,"median":-5.878491,"eighty":-3.148277,"marketCap":980173379},{"date":"2021-07-02","current":-23.092758,"twenty":-15.652351,"median":-5.917145,"eighty":-3.156328,"marketCap":865978422},{"date":"2021-07-09","current":-23.051735,"twenty":-15.761853,"median":-5.937087,"eighty":-3.167329,"marketCap":865978422},{"date":"2021-07-16","current":-20.775023,"twenty":-15.95183,"median":-6.007364,"eighty":-3.195956,"marketCap":776763612},{"date":"2021-07-23","current":-22.035114,"twenty":-16.063497,"median":-6.041838,"eighty":-3.238571,"marketCap":820776252},{"date":"2021-07-30","current":-21.059372,"twenty":-16.128752,"median":-6.076909,"eighty":-3.259095,"marketCap":791037982},{"date":"2021-08-06","current":-21.588025,"twenty":-16.223152,"median":-6.17599,"eighty":-3.285825,"marketCap":804122820},{"date":"2021-08-13","current":-19.386614,"twenty":-16.267348,"median":-6.189786,"eighty":-3.306793,"marketCap":724424257},{"date":"2021-08-20","current":-18.425725,"twenty":-16.267348,"median":-6.189786,"eighty":-3.306793,"marketCap":681601148},{"date":"2021-08-27","current":-22.970928,"twenty":-16.347746,"median":-6.189786,"eighty":-3.306793,"marketCap":857651706},{"date":"2021-09-03","current":-21.148347,"twenty":-16.436016,"median":-6.189786,"eighty":-3.306793,"marketCap":795796105},{"date":"2021-09-10","current":-17.179979,"twenty":-16.436016,"median":-6.189786,"eighty":-3.306793,"marketCap":775862809},{"date":"2021-09-17","current":-17.071624,"twenty":-16.436016,"median":-6.189786,"eighty":-3.306793,"marketCap":765086936},{"date":"2021-09-24","current":-16.765542,"twenty":-16.436016,"median":-6.189786,"eighty":-3.306793,"marketCap":749521787},{"date":"2021-10-01","current":-16.663858,"twenty":-16.347746,"median":-6.189786,"eighty":-3.306793,"marketCap":737548596},{"date":"2021-10-08","current":-15.446292,"twenty":-16.210382,"median":-6.189786,"eighty":-3.306793,"marketCap":682471915},{"date":"2021-10-15","current":-15.976444,"twenty":-16.210382,"median":-6.189786,"eighty":-3.306793,"marketCap":707615617},{"date":"2021-10-22","current":-16.149501,"twenty":-16.234516,"median":-6.189786,"eighty":-3.306793,"marketCap":717194170},{"date":"2021-10-29","current":-18.442083,"twenty":-16.480892,"median":-6.189786,"eighty":-3.306793,"marketCap":814177022},{"date":"2021-11-05","current":-18.34632,"twenty":-16.580432,"median":-6.217099,"eighty":-3.316607,"marketCap":809387745},{"date":"2021-11-12","current":-12.887867,"twenty":-16.636257,"median":-6.366972,"eighty":-3.347851,"marketCap":727504245},{"date":"2021-11-19","current":-14.840685,"twenty":-16.636257,"median":-6.379385,"eighty":-3.347851,"marketCap":828443920},{"date":"2021-11-26","current":-15.376883,"twenty":-16.636257,"median":-6.466623,"eighty":-3.347851,"marketCap":857987240},{"date":"2021-12-03","current":-13.424683,"twenty":-16.636257,"median":-6.575497,"eighty":-3.377218,"marketCap":747199791},{"date":"2021-12-10","current":-12.997179,"twenty":-16.636257,"median":-6.657218,"eighty":-3.396061,"marketCap":725042301},{"date":"2021-12-17","current":-12.509898,"twenty":-16.636257,"median":-6.728698,"eighty":-3.423779,"marketCap":695498982},{"date":"2021-12-23","current":-13.038361,"twenty":-16.636257,"median":-6.858132,"eighty":-3.442283,"marketCap":727504245},{"date":"2021-12-31","current":-12.117326,"twenty":-16.636257,"median":-6.884208,"eighty":-3.46119,"marketCap":679496350},{"date":"2022-01-07","current":-10.610792,"twenty":-16.627056,"median":-6.916981,"eighty":-3.461316,"marketCap":593328335},{"date":"2022-01-14","current":-9.704425,"twenty":-16.627056,"median":-7.019716,"eighty":-3.465806,"marketCap":546551412},{"date":"2022-01-21","current":-8.848661,"twenty":-16.627056,"median":-7.131619,"eighty":-3.488997,"marketCap":494850603},{"date":"2022-01-28","current":-8.610947,"twenty":-16.627056,"median":-7.186433,"eighty":-3.495073,"marketCap":473924085},{"date":"2022-02-04","current":-8.486762,"twenty":-16.627056,"median":-7.262988,"eighty":-3.495073,"marketCap":478847971},{"date":"2022-02-11","current":-9.215381,"twenty":-16.627056,"median":-7.311647,"eighty":-3.495073,"marketCap":518239064},{"date":"2022-02-18","current":-9.296268,"twenty":-16.627056,"median":-7.390935,"eighty":-3.495073,"marketCap":519470036},{"date":"2022-02-25","current":-10.170929,"twenty":-16.627056,"median":-7.44128,"eighty":-3.495073,"marketCap":565015987},{"date":"2022-03-04","current":-9.35501,"twenty":-16.627056,"median":-7.524235,"eighty":-3.495073,"marketCap":503467404},{"date":"2022-03-11","current":-10.192934,"twenty":-16.627056,"median":-7.590411,"eighty":-3.495073,"marketCap":550244327},{"date":"2022-03-18","current":-9.659238,"twenty":-16.627056,"median":-7.983628,"eighty":-3.495073,"marketCap":526855866},{"date":"2022-03-25","current":-9.906181,"twenty":-16.627056,"median":-8.203742,"eighty":-3.495073,"marketCap":536703639},{"date":"2022-04-01","current":-9.118644,"twenty":-16.627056,"median":-8.386389,"eighty":-3.495073,"marketCap":578953382},{"date":"2022-04-08","current":-8.740523,"twenty":-16.627056,"median":-8.443056,"eighty":-3.495073,"marketCap":546857885},{"date":"2022-04-14","current":-9.834883,"twenty":-16.627056,"median":-8.605682,"eighty":-3.495073,"marketCap":611403844},{"date":"2022-04-22","current":-9.366131,"twenty":-16.627056,"median":-8.785182,"eighty":-3.495073,"marketCap":580756663},{"date":"2022-04-29","current":-9.260008,"twenty":-16.627056,"median":-9.01305,"eighty":-3.495073,"marketCap":561348342},{"date":"2022-05-06","current":-8.378286,"twenty":-16.627056,"median":-9.116756,"eighty":-3.495073,"marketCap":510588120},{"date":"2022-05-13","current":-8.153397,"twenty":-16.627056,"median":-9.116756,"eighty":-3.495073,"marketCap":488193904},{"date":"2022-05-20","current":-8.069367,"twenty":-16.627056,"median":-9.116756,"eighty":-3.499997,"marketCap":489686852},{"date":"2022-05-27","current":-7.752127,"twenty":-16.627056,"median":-9.116756,"eighty":-3.533184,"marketCap":477743270},{"date":"2022-06-03","current":-5.71171,"twenty":-16.627056,"median":-9.116756,"eighty":-3.545748,"marketCap":462813793},{"date":"2022-06-10","current":-4.879293,"twenty":-16.627056,"median":-9.116756,"eighty":-3.57999,"marketCap":388166407},{"date":"2022-06-17","current":-4.680541,"twenty":-16.627056,"median":-9.116756,"eighty":-3.612423,"marketCap":370251034},{"date":"2022-06-24","current":-5.073415,"twenty":-16.636257,"median":-9.118644,"eighty":-3.625384,"marketCap":404588832},{"date":"2022-07-01","current":-5.334985,"twenty":-16.636257,"median":-9.118644,"eighty":-3.643951,"marketCap":419518309},{"date":"2022-07-08","current":-6.034146,"twenty":-16.636257,"median":-9.118644,"eighty":-3.668976,"marketCap":464306740},{"date":"2022-07-15","current":-5.694944,"twenty":-16.636257,"median":-9.118644,"eighty":-3.695939,"marketCap":434447786},{"date":"2022-07-22","current":-5.717974,"twenty":-16.636257,"median":-9.118644,"eighty":-3.744127,"marketCap":441912525},{"date":"2022-07-29","current":-5.479142,"twenty":-16.636257,"median":-9.118644,"eighty":-3.792324,"marketCap":422504204},{"date":"2022-08-05","current":-6.416476,"twenty":-16.636257,"median":-9.118644,"eighty":-3.830801,"marketCap":492672747},{"date":"2022-08-12","current":-5.825491,"twenty":-16.636257,"median":-9.118644,"eighty":-3.963778,"marketCap":455484971},{"date":"2022-08-19","current":-5.871111,"twenty":-16.636257,"median":-9.118644,"eighty":-4.242442,"marketCap":449511398},{"date":"2022-08-26","current":-5.309834,"twenty":-16.636257,"median":-9.118644,"eighty":-4.319545,"marketCap":404709597},{"date":"2022-09-02","current":-5.114507,"twenty":-16.636257,"median":-9.118644,"eighty":-4.43826,"marketCap":391269057},{"date":"2022-09-09","current":-5.344467,"twenty":-16.636257,"median":-9.118644,"eighty":-4.536362,"marketCap":409189777},{"date":"2022-09-16","current":-4.357555,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":333026717},{"date":"2022-09-23","current":-4.028365,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":298678670},{"date":"2022-09-30","current":-4.114118,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":307639030},{"date":"2022-10-07","current":-3.80611,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":283744736},{"date":"2022-10-14","current":-3.054413,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":226995789},{"date":"2022-10-21","current":-3.314609,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":247903296},{"date":"2022-10-28","current":-3.486071,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":264330622},{"date":"2022-11-04","current":-3.852425,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681553,"marketCap":291211703},{"date":"2022-11-11","current":-4.114521,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":324066356},{"date":"2022-11-18","current":-3.867026,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":303158850},{"date":"2022-11-25","current":-3.967708,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":312119210},{"date":"2022-12-02","current":-3.934702,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":312119210},{"date":"2022-12-09","current":-3.821241,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":304652243},{"date":"2022-12-16","current":-2.085113,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":167260055},{"date":"2022-12-23","current":-2.155917,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":173233628},{"date":"2022-12-30","current":-2.290404,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":185180775},{"date":"2023-01-06","current":-2.231917,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":179207202},{"date":"2023-01-13","current":-2.080039,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":170246841},{"date":"2023-01-20","current":-2.222395,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":182193988},{"date":"2023-01-27","current":-2.200357,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":180700595},{"date":"2023-02-03","current":-2.182882,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":179207202},{"date":"2023-02-10","current":-1.977875,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":159793088},{"date":"2023-02-17","current":-1.888271,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":152326121},{"date":"2023-02-24","current":-1.703345,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":135958530},{"date":"2023-03-03","current":-1.679422,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":134674212},{"date":"2023-03-10","current":-1.414975,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":114169921},{"date":"2023-03-17","current":-1.407397,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":113497894},{"date":"2023-03-24","current":-1.066811,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":98698366},{"date":"2023-03-31","current":-1.191621,"twenty":-16.627056,"median":-9.116756,"eighty":-4.681259,"marketCap":111347408},{"date":"2023-04-06","current":-1.164389,"twenty":-16.627056,"median":-9.116756,"eighty":-4.681259,"marketCap":109361195},{"date":"2023-04-14","current":-1.131675,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":107569123},{"date":"2023-04-21","current":-1.288641,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":121562218},{"date":"2023-04-28","current":-1.417911,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":134405401},{"date":"2023-05-05","current":-1.362025,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":128894780},{"date":"2023-05-12","current":-1.456479,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":136779896},{"date":"2023-05-19","current":-1.560045,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":144470872},{"date":"2023-05-26","current":-1.200289,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":130432975},{"date":"2023-06-02","current":-1.17182,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":127476056},{"date":"2023-06-09","current":-0.951535,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":103880441},{"date":"2023-06-16","current":-0.945126,"twenty":-16.636257,"median":-9.118644,"eighty":-4.681911,"marketCap":104612204},{"date":"2023-06-23","current":-0.914728,"twenty":-16.645457,"median":-9.147315,"eighty":-4.695857,"marketCap":101580615},{"date":"2023-06-30","current":-0.813625,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":89752940},{"date":"2023-07-07","current":-0.719146,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":79149847},{"date":"2023-07-14","current":-0.860258,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":97563387},{"date":"2023-07-21","current":-0.813534,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":91873558},{"date":"2023-07-28","current":-0.764432,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":85123420},{"date":"2023-08-04","current":-0.790173,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":87662189},{"date":"2023-08-11","current":-0.661969,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":81165928},{"date":"2023-08-18","current":-0.629036,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":76163060},{"date":"2023-08-25","current":-0.688136,"twenty":-16.654658,"median":-9.175986,"eighty":-4.718916,"marketCap":82958000},{"date":"2023-09-01","current":-0.672942,"twenty":-16.654658,"median":-9.093792,"eighty":-4.674708,"marketCap":81240598},{"date":"2023-09-08","current":-0.653228,"twenty":-16.654658,"median":-9.000893,"eighty":-4.549706,"marketCap":77805793},{"date":"2023-09-15","current":-0.637716,"twenty":-16.654658,"median":-9.000893,"eighty":-4.423794,"marketCap":75715042},{"date":"2023-09-22","current":-0.599293,"twenty":-16.654658,"median":-9.000893,"eighty":-4.33,"marketCap":71130325},{"date":"2023-09-29","current":-0.622184,"twenty":-16.654658,"median":-9.000893,"eighty":-4.247579,"marketCap":73176274},{"date":"2023-10-06","current":-0.596639,"twenty":-16.654658,"median":-9.000893,"eighty":-4.112352,"marketCap":69920676},{"date":"2023-10-13","current":-0.546806,"twenty":-16.654658,"median":-9.000893,"eighty":-4.053568,"marketCap":64215914},{"date":"2023-10-20","current":-0.458456,"twenty":-16.654658,"median":-9.000893,"eighty":-4.008292,"marketCap":53971235},{"date":"2023-10-27","current":-0.433179,"twenty":-16.666362,"median":-9.059499,"eighty":-3.976432,"marketCap":50775373},{"date":"2023-11-03","current":-0.442351,"twenty":-16.666362,"median":-9.059499,"eighty":-3.873624,"marketCap":52268767},{"date":"2023-11-10","current":-0.440363,"twenty":-16.666362,"median":-9.059499,"eighty":-3.830423,"marketCap":52507710},{"date":"2023-11-17","current":-0.426844,"twenty":-16.666362,"median":-9.059499,"eighty":-3.664691,"marketCap":55255553},{"date":"2023-11-24","current":-0.534341,"twenty":-16.666362,"median":-9.059499,"eighty":-3.433533,"marketCap":69442790},{"date":"2023-12-01","current":-0.517048,"twenty":-16.666362,"median":-9.059499,"eighty":-3.222223,"marketCap":67202700},{"date":"2023-12-08","current":-0.464379,"twenty":-16.66511,"median":-9.025206,"eighty":-3.086164,"marketCap":59705866},{"date":"2023-12-15","current":-0.457712,"twenty":-16.66511,"median":-9.025206,"eighty":-2.88022,"marketCap":59974676},{"date":"2023-12-22","current":-0.518687,"twenty":-16.66511,"median":-9.025206,"eighty":-2.313602,"marketCap":67949397},{"date":"2023-12-29","current":-0.609672,"twenty":-16.666362,"median":-9.059499,"eighty":-2.285249,"marketCap":80478967},{"date":"2024-01-05","current":-0.754698,"twenty":-16.667613,"median":-9.093792,"eighty":-2.227796,"marketCap":98563961},{"date":"2024-01-12","current":-0.758876,"twenty":-16.667613,"median":-9.093792,"eighty":-2.18417,"marketCap":99011979},{"date":"2024-01-19","current":-0.695835,"twenty":-16.668865,"median":-9.098987,"eighty":-2.171239,"marketCap":90096420},{"date":"2024-01-26","current":-0.666586,"twenty":-16.667613,"median":-9.093792,"eighty":-2.137661,"marketCap":86094126},{"date":"2024-02-02","current":-0.644566,"twenty":-16.667613,"median":-9.093792,"eighty":-2.091744,"marketCap":83331348},{"date":"2024-02-09","current":-0.617353,"twenty":-16.667613,"median":-9.093792,"eighty":-2.052133,"marketCap":79194649},{"date":"2024-02-16","current":-0.67511,"twenty":-16.667613,"median":-9.093792,"eighty":-1.975908,"marketCap":86557078},{"date":"2024-02-23","current":-0.617491,"twenty":-16.667613,"median":-9.093792,"eighty":-1.947684,"marketCap":79597865},{"date":"2024-03-01","current":-0.697882,"twenty":-16.666362,"median":-9.059499,"eighty":-1.779013,"marketCap":89902279},{"date":"2024-03-08","current":-0.667559,"twenty":-16.666362,"median":-9.059499,"eighty":-1.688003,"marketCap":86945360},{"date":"2024-03-15","current":-0.506219,"twenty":-16.666362,"median":-9.059499,"eighty":-1.634497,"marketCap":65709305},{"date":"2024-03-22","current":-0.58162,"twenty":-16.666362,"median":-9.059499,"eighty":-1.510924,"marketCap":75267022},{"date":"2024-03-28","current":-0.618359,"twenty":-16.666362,"median":-9.01305,"eighty":-1.459806,"marketCap":79597862},{"date":"2024-04-05","current":-0.866738,"twenty":-16.667613,"median":-8.751193,"eighty":-1.422262,"marketCap":99739882},{"date":"2024-04-12","current":-0.793178,"twenty":-16.667613,"median":-8.486762,"eighty":-1.405578,"marketCap":89994306},{"date":"2024-04-19","current":-0.68343,"twenty":-16.667613,"median":-8.38839,"eighty":-1.387362,"marketCap":77203237},{"date":"2024-04-26","current":-0.654802,"twenty":-16.666362,"median":-8.297522,"eighty":-1.359235,"marketCap":74310019},{"date":"2024-05-03","current":-0.712072,"twenty":-16.666362,"median":-8.159542,"eighty":-1.305557,"marketCap":80705553},{"date":"2024-05-10","current":-0.698373,"twenty":-16.666362,"median":-7.962823,"eighty":-1.211671,"marketCap":79715768},{"date":"2024-05-17","current":-0.719387,"twenty":-16.666362,"median":-7.584088,"eighty":-1.190792,"marketCap":82837398},{"date":"2024-05-24","current":-0.625491,"twenty":-16.605198,"median":-7.459668,"eighty":-1.173371,"marketCap":71721350},{"date":"2024-05-31","current":-0.538179,"twenty":-16.547277,"median":-7.330718,"eighty":-1.135454,"marketCap":61823499},{"date":"2024-06-07","current":-0.833529,"twenty":-16.367417,"median":-7.251948,"eighty":-1.092422,"marketCap":96085291},{"date":"2024-06-14","current":-1.076961,"twenty":-16.216128,"median":-7.153247,"eighty":-1.047656,"marketCap":107962712},{"date":"2024-06-21","current":-0.900253,"twenty":-16.103411,"median":-6.971526,"eighty":-1.029529,"marketCap":89842031},{"date":"2024-06-28","current":-0.832391,"twenty":-16.088535,"median":-6.884208,"eighty":-1.025183,"marketCap":82989673},{"date":"2024-07-05","current":-0.769835,"twenty":-16.050689,"median":-6.862373,"eighty":-0.971158,"marketCap":77507786},{"date":"2024-07-12","current":-0.773111,"twenty":-15.94919,"median":-6.676714,"eighty":-0.930447,"marketCap":78269159},{"date":"2024-07-15","current":-0.771499,"twenty":-15.918173,"median":-6.669735,"eighty":-0.921229,"marketCap":78421434},{"date":"2024-08-02","current":-0.768634,"twenty":-15.595333,"median":-6.400421,"eighty":-0.883653,"marketCap":77203237},{"date":"2024-08-09","current":-0.632456,"twenty":-15.510732,"median":-6.313644,"eighty":-0.860258,"marketCap":64259893},{"date":"2024-08-16","current":-0.587986,"twenty":-15.510732,"median":-6.22595,"eighty":-0.839961,"marketCap":60148478},{"date":"2024-08-23","current":-0.60796,"twenty":-15.510732,"median":-6.118573,"eighty":-0.829932,"marketCap":62889422},{"date":"2024-08-30","current":-0.652457,"twenty":-15.510732,"median":-6.068692,"eighty":-0.821487,"marketCap":67305386},{"date":"2024-09-06","current":-0.657393,"twenty":-15.510732,"median":-6.008299,"eighty":-0.81624,"marketCap":57712084},{"date":"2024-09-13","current":-0.694471,"twenty":-15.510732,"median":-5.956583,"eighty":-0.803693,"marketCap":60684576},{"date":"2024-09-20","current":-0.704034,"twenty":-15.427137,"median":-5.910835,"eighty":-0.793178,"marketCap":62095845},{"date":"2024-09-27","current":-0.584669,"twenty":-15.32092,"median":-5.878635,"eighty":-0.782442,"marketCap":51746537},{"date":"2024-10-04","current":-0.586104,"twenty":-15.301899,"median":-5.855288,"eighty":-0.773111,"marketCap":51119306},{"date":"2024-10-11","current":-0.541943,"twenty":-15.301899,"median":-5.800352,"eighty":-0.769835,"marketCap":46885499},{"date":"2024-10-18","current":-0.605318,"twenty":-15.301899,"median":-5.777876,"eighty":-0.761077,"marketCap":51903345},{"date":"2024-10-25","current":-0.608659,"twenty":-15.301899,"median":-5.737735,"eighty":-0.754698,"marketCap":52060153},{"date":"2024-10-31","current":-0.609151,"twenty":-15.301899,"median":-5.716739,"eighty":-0.742491,"marketCap":52373768},{"date":"2024-11-08","current":-0.703144,"twenty":-15.305703,"median":-5.703279,"eighty":-0.728568,"marketCap":60057345},{"date":"2024-11-15","current":-0.68318,"twenty":-15.305703,"median":-5.667174,"eighty":-0.719586,"marketCap":57234806},{"date":"2024-11-22","current":-0.564013,"twenty":-15.261474,"median":-5.609749,"eighty":-0.715836,"marketCap":41397230},{"date":"2024-11-29","current":-0.630681,"twenty":-15.116002,"median":-5.543233,"eighty":-0.712623,"marketCap":46554254},{"date":"2024-12-06","current":-0.514226,"twenty":-15.0537,"median":-5.513755,"eighty":-0.708442,"marketCap":38030235},{"date":"2024-12-13","current":-0.486923,"twenty":-14.993946,"median":-5.479142,"eighty":-0.703242,"marketCap":35735307},{"date":"2024-12-20","current":-0.266274,"twenty":-14.884839,"median":-5.460841,"eighty":-0.699116,"marketCap":19342964},{"date":"2024-12-27","current":-0.285689,"twenty":-14.814753,"median":-5.441097,"eighty":-0.698048,"marketCap":20818275},{"date":"2025-01-03","current":-0.308399,"twenty":-14.738545,"median":-5.391395,"eighty":-0.695762,"marketCap":22129663},{"date":"2025-01-10","current":-0.270816,"twenty":-14.53351,"median":-5.348883,"eighty":-0.692407,"marketCap":19506888},{"date":"2025-01-17","current":-0.245783,"twenty":-14.325984,"median":-5.329539,"eighty":-0.684921,"marketCap":17703730},{"date":"2025-01-24","current":-0.249775,"twenty":-14.132925,"median":-5.314231,"eighty":-0.683182,"marketCap":18195500},{"date":"2025-01-31","current":-0.220112,"twenty":-13.932511,"median":-5.295087,"eighty":-0.680028,"marketCap":16054660},{"date":"2025-02-07","current":-0.237086,"twenty":-13.611089,"median":-5.258828,"eighty":-0.67681,"marketCap":17211960},{"date":"2025-02-14","current":-0.237779,"twenty":-13.404681,"median":-5.199312,"eighty":-0.673691,"marketCap":17375883},{"date":"2025-02-21","current":-0.228352,"twenty":-13.113781,"median":-5.16143,"eighty":-0.671498,"marketCap":16720189},{"date":"2025-02-28","current":-0.234146,"twenty":-13.004303,"median":-5.093127,"eighty":-0.66717,"marketCap":17048036},{"date":"2025-03-07","current":-0.214168,"twenty":-12.833741,"median":-4.905386,"eighty":-0.659364,"marketCap":16228419},{"date":"2025-03-14","current":-0.188911,"twenty":-12.833741,"median":-4.806252,"eighty":-0.656938,"marketCap":14359692},{"date":"2025-03-21","current":-0.193671,"twenty":-12.833741,"median":-4.682227,"eighty":-0.654063,"marketCap":14703931},{"date":"2025-03-28","current":-0.174713,"twenty":-12.833741,"median":-4.546839,"eighty":-0.649788,"marketCap":13195836},{"date":"2025-04-04","current":-0.13376,"twenty":-12.833741,"median":-4.392747,"eighty":-0.645221,"marketCap":10359960},{"date":"2025-04-11","current":-0.131126,"twenty":-12.743296,"median":-4.321448,"eighty":-0.639055,"marketCap":10261606},{"date":"2025-04-17","current":-0.149573,"twenty":-12.569364,"median":-4.252259,"eighty":-0.638148,"marketCap":11900841},{"date":"2025-04-25","current":-0.183631,"twenty":-12.517515,"median":-4.11191,"eighty":-0.635556,"marketCap":14589185},{"date":"2025-04-28","current":-0.19246,"twenty":-12.502564,"median":-4.11121,"eighty":-0.634381,"marketCap":15321923}],"updateTime":1746000610612}}}